Neoadjuvant Icotinib With Chemotherapy for Resectable Stage II-IIIB N2 EGFR Mutation-positive Lung Adenocarcinoma: A Phase II Study
Latest Information Update: 13 Dec 2021
At a glance
- Drugs Carboplatin (Primary) ; Cisplatin (Primary) ; Icotinib (Primary) ; Pemetrexed (Primary)
- Indications Adenocarcinoma; Lung cancer; Non-small cell lung cancer
- Focus Therapeutic Use
- 29 Nov 2021 New trial record